新闻中心 - Antibodies-Online中国区代理商/公司/官网

欢迎来到 Antibodies-Online中国区代理商/公司/官网

全国咨询热线： 18995651644

Antibodies-Online中国区代理商/公司/官网

产品中心

推荐产品

invivoCrown IV0118替换BioXCell BE0055

invivoCrown IV0114替换BioXCell BE0213

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：18771997407

传真：13212737804

邮箱：sales@amyjet.com

新闻中心

首页 > 新闻中心

艾美捷科技代理法国Lallemand品牌品牌。

Lallemand公司是一家全球领先的酵母、细菌和相关产品生产商，成立于19世纪末，总部位于加拿大蒙特利尔。Lallemand 专注于酵母和微生物技术的研发、生产和应用，其产品广泛应用于烘焙、酿酒、营养保健品、动物营养、制药和生物技术等领域。Lallemand特色产品包括：FNI Series 1系列酵母提取物、FNI Series 3灭活酵母和自溶物、FNI Series8 酵母蛋白胨，不含动物和奶制品成分、非转基因、无过敏源。Lallemand 拥有强大的研发团队和先进的生物技术平台，致力于开发创新的酵母和微生物解决方案。公司与科研机构、大学和行业合作伙伴紧密合作，推动微生物技术的应用和发展。

" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理法国Lallemand品牌"> 艾美捷科技代理法国Lallemand品牌

...

阅读详情

ReliaTech全称为受体配体技术有限公司 (Receptor Ligand Technologies GmbH)位于德国不伦瑞克，是一家后基因组生物技术公司。公司运用独特技术专注于受体和配体的发现与研究。除其他研究试剂，ReliaTech也开发应用于血管与淋巴管生成研究的相关高品质试剂。产品主要包括重组蛋白(细胞因子、生长因子、可溶性受体)、抗体、ELISA试剂盒等。

ReliaTech GmbH (short for Receptor Ligand Technologies GmbH) is a post-genomic German biotechnology company founded in 1999. Besides other research products the company develops, produces and sells high quality research reagents for angiogenic and lymphangiogenic research.

As a company with own in-house reagent production ReliaTech GmbH also offers solutions for customer specific reagent production. Our profound experiences in protein purification and our practical knowledge in daily laboratory business also flow into our customer based projects - making us a competent partner for projects requiring individual production solutions.

Reliatech的主要产品包括：

Recombinant Proteins

Antibodies

ELISA Kits

Specialities

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Reliatech"> Reliatech

...

阅读详情

DiaMetra公司位于意大利Perugia，致力于为诊断行业提供高品质产品，包括标品和检测试剂盒，涉及的检测领域包括：唾液试剂盒、高血压及钙的代谢、自体免疫疾病、糖尿病指标检测、肿瘤标志物、固醇类激素、性激素、甲状腺激素检测等。

Diametra is dedicated to providing quality products and the highest level of service in its target diagnostics segments. Through innovation and total commitment we strive to create value for our people, our customers and for the shareholders.

As an organization we constantly strive for innovation, not simply in the products we bring to the market but also in the way we interact with our customers and with each other. This is grounded in our solution driven approach to partnership.

产品主要应用领域：

Saliva kits

Hypertension / Calcium Metabolism

Controls

Autoimmune Diseases

Diabetes Monitoring

Tumor Markers

Steroids Hormones

Fertility Proteic Hormones

Thyroid Monitoring

Circulating Immuno Complexes

Miscellaneous

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="DiaMetra"> DiaMetra

...

阅读详情

Optocell公司是制药和生物技术市场上游生物工艺监控系统的可靠供应商。凭借对哺乳动物细胞、细菌、酵母和藻类培养的深入了解，Optocell支持在研发、工艺开发和生产阶段对生物工艺进行在线分析。

Optocell is a trusted supplier of monitoring systems for upstream bioprocesses to the Pharma and Biotech market. With the in-depth knowledge of the cultivation of mammalian cells, bacteria, yeast and algae we support the at-line analysis of bioprocesses in the stages of R&D, process development and production.

Optocell的主要产品包括：

BioMajesty

CuBiAn HT270

CuBiAn C125

Reagents

ConSta

LinSta

FocSta

ViaSta

LinSta EASY

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

< " data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Optocell"> Optocell

...

阅读详情

ScreenFect-Logo_neu_21_2c08d653e1ee60d55cd0da551026ea56.png

艾美捷科技代理Screenfect品牌全系列产品

ScreenFect GmbH成立于2012年，是一家专注于细胞转染技术创新的德国生物技术公司。ScreenFect®转染试剂是该公司的核心产品，是依托组合化学方法构建独特化学文库，通过高通量细胞筛选平台高效开发的转染试剂。ScreenFect®转染试剂适用于多种核酸分子（包括pDNA、siRNA、mRNA、miRNA）的单转染与共转染，在难转染细胞（如原代细胞、干细胞）中具有优异性能。

▎ScreenFect®转染试剂

● ScreenFect®A是一款通用型转染试剂，适用于pDNA、siRNA、mRNA的递送以及共转染实验，可广泛应用于多种细胞系（如HEK、HeLa、MEF）及部分原代细胞系。高效转染：在96孔板中仅需低于100ng DNA即可实现高转染效率。

● ScreenFect®siRN 是转染小干扰RNA双链体的理想选择，适用于HEK、HeLa、MEF等标准哺乳动物细胞系及多种原代细胞系。

● ScreenFect®mRNA是专为mRNA转染优化的高效试剂。

● ScreenFect®A-plus是一款多功能增强型转染试剂，适用于pDNA、siRNA、mRNA的转染及共转染实验，在几乎所有细胞系（包括难转染细胞）中均能实现高效转染。

货号	品名	规格	Dilution buffer
S-3001	ScreenFect®A	1 mL	50 mL
S-3001-2	ScreenFect®A	0,2 mL	10 mL
S-4001	ScreenFect®siRNA	1 mL	50 mL
S-4001-2	ScreenFect®siRNA	0,2 mL	10 mL
S-5001	ScreenFect®mRNA	1 mL	50 mL
S-5001-2	ScreenFect®mRNA	0,2 mL	10 mL
S-6001	ScreenFect®A-plus	1 mL	50 mL
S-6001-2	ScreenFect®A-plus	0,2 mL	10 mL
S-2001-2	ScreenFect Buffer	10 mL	-
S-2001	ScreenFect Buffer	50 mL	-

ScreenFect®转染试剂具有以下特点：

● 低细胞毒性：显著降低对细胞活性的影响

● 省时一步法：支持细胞铺板与转染同步操作（即用型方案）

● 快速优化：针对新用户/新细胞系提供简易优化流程

● 血清兼容性：无需更换培养基，可直接在含血清环境下使用

● 无动物源成分：杜绝动物源性物质污染风险

● 高通量适用：完美适配大规模筛选实验需求

▎ScreenFect®UP-293

ScreenFect®UP-293 是一款专为高效生产抗体及蛋白设计的转染试剂，适用于HEK 293-F悬浮细胞体系。配合ScreenFect®Booster增效剂使用，可最大化提升悬浮细胞中的蛋白产量。

产品编号	悬浮培养体积	组分	组分体积
S-8010-0.5L	0.5 litre	ScreenFect®UP-293	1 mL
		ScreenFect®Booster	2.5 mL
		ScreenFect®Buffer	35 mL
S-8010-1L	1 litre	ScreenFect®UP-293	2 mL
		ScreenFect®Booster	5 mL
		ScreenFect®Buffer	70 mL
S-8010-10L	10 litres	ScreenFect®UP-293	20 mL
		ScreenFect®Booster	50 mL
		ScreenFect®Buffer	700 mL
S-8010-50L	50 litres	ScreenFect®UP-293	100 mL
		ScreenFect®Booster	250 mL
		ScreenFect®Buffer	3.5 L

▎ScreenFect®Booster

在完成HEK293F悬浮细胞的ScreenFect®UP-293转染后，于转染后16小时添加ScreenFect®Booster增效剂，可显著提升蛋白产量。该增效剂含特定复合组分，通过重编程细胞代谢路径（从增殖模式转向蛋白合成模式），从而高效提升大多数目标蛋白的表达水平。

货号	品名	规格
S-2001-2	ScreenFect Buffer	10 mL
S-2001	ScreenFect Buffer	50 mL

" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Screenfect品牌全系列产品"> 艾美捷科技代理Screenfect品牌全系列产品

...

阅读详情

美国Cell Sciences公司是一家为生命科学研究领域提供免疫化学和血液学试剂的专业供货商。该公司主要产品有重组细胞因子、细胞因子受体、趋化因子、激酶、磷酸酶、Elisa与Elispot试剂盒、单克隆抗体、多克隆抗体与抗体配对等相关实验服务，并提供用于Elisa实验的细胞因子配对抗体，单个细胞因子检测试剂盒等产品。

Cell Sciences supplies thousands of laboratory reagents, such as antibodies, proteins and immunoassay kits, to assist scientists in life science research.

Cell Sciences 的主要产品包括：

Proteins

Antibodies

Kits

Tissues, Fluids & Lysates

Small Molecules

Misc. Reagents

" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Cell Sciences"> Cell Sciences

...

阅读详情

艾美捷科技代理Berry & Associates全系列修饰核苷酸等

美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.

Berry & Associates的主要产品包括：

产品名称	产品编号	纯度	规格
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2'-3'-Dideoxyguanosine	PR 3505	≥95%	25 mg; 100 mg
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
2',3'-Dideoxyuridine	PY 7278	≥97%	100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridine	PY 7279	≥97%	25 mg; 100 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
2-Amino-2'-deoxyadenosine	PR 3060	≥97%	1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine	PR 3080	≥95%	100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosine	PR 3130	≥95%	100 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3670	≥95%	100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine	PR 3070	≥97%	25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine	PR 3160	≥97%	100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate	PR 3180	≥97%	25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3680	≥97%	100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosine	PR 3006	≥95%	25 mg; 100 mg
8-Amino-2'-deoxyadenosine	PR 3115	≥97%	10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosine	PR 3120	≥90%	100 mg; 1 g
8-Azido-2'-deoxyadenosine	PR 3125	≥97%	10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine	PR 3230	≥95%	50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine	PR 3260	≥95%	100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosine	PR 3280	≥97%	100 mg; 1 g
8-Bromo-2'-deoxyadenosine	PR 3290	≥90%	2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3320	≥95%	100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3340	≥97%	0g (discontinued);
2'-Deoxyadenosine Monohydrate	PR 3445	≥97%	25 g; 100 g
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2-Fluoro-2'-deoxyadenosine	PR 3496	≥97%	25 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
N6-Methyl-2'-deoxyadenosine	PR 3740	≥97%	100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine	PRA 10012	≥95%	10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine	PRA 10032	≥95%	10 mg; 50 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosine	PR 3010	≥90%	0Discontinued;
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3015	≥90%	1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3020	≥90%	1 g; 10 g
5'-Azido-5'-deoxyguanosine	PR 3225	≥90%	5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3285	≥90%	1 g; 10 g
8-Bromo-2'-deoxyguanosine	PR 3300	≥90%	1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine	PR 3310	≥97%	500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3330	≥90%	250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine	PR 3335	≥95%	100 mg; 1 g
2'-Deoxyguanosine monohydrate	PR 3452	≥97%	10 g; 100 g
α-2'-Deoxyguanosine	PR 3455	≥97%	10 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine	PR 3600	≥97%	100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosine	PR 3605	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine	PR 3630	≥97%	100 mg; 1 g
N2-Ethyl-2'-deoxyguanosine	PR 3700	≥95%	25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosine	PR 3745	≥97%	10 mg; 100 mg
N1-Methyl-2'-deoxyguanosine	PR 3748	≥97%	25 mg; 1 g
N2-Methyl-2'-deoxyguanosine	PR 3750	≥97%	25 mg; 100 mg
O6-Methyl-2'-deoxyguanosine	PR 3755	≥90%	5 mg; 25 mg
6-Thio-2'-deoxyguanosine	PR 3845	≥97%	10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
2'-O-Methyladenosine	PR 3734	≥97%	1 g;
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridine	PY 7575	≥97%	10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridine	PY 7577	≥97%	10 mg; 100 mg
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine	PR 3000	≥97%	25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine	PR 3200	≥90%	50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosine	PR 3210	≥97%	10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosine	PR 3220	≥97%	10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosine	PR 3240	≥97%	100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine	PR 3250	≥97%	100 mg; 1 g
3'-Deoxyadenosine	PR 3430	≥97%	10 mg; 100 mg
3'-Deoxyguanosine	PR 3460	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine	PR 3590	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosine	PR 3690	≥97%	20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine	PY 7230	≥97%	100 mg;
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3040	≥97%	1 g;
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3045	≥95%	1 g;
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine	PR 3050	≥95%	5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3370	≥97%	100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3380	≥90%	100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine	PR 3390	≥97%	0 g;
6-Chloro-9-(β-D-ribofuranosyl)purine	PR 3400	≥97%	5 g; 10 g
Adenosine	PR 3005	≥97%	100 g; 1 kg
8-Methyladenosine	PR 3007	≥95%	25 mg; 100 mg
Vidarabine	PR 3008	≥97%	1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
N1-Methyladenosine hydroiodide	PR 3032	≥95%	100 mg; 1 g
2-Methyladenosine	PR 3035	≥97%	10 mg; 25 mg
5'-Chloro-5'-deoxyadenosine	PR 3360	≥97%	100 mg; 1 g
N6-Methyladenosine	PR 3732	≥97%	100 mg; 1 g
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10000	≥97%	100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10005	≥97%	500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine	PRA 10006	≥90%	25 mg; 100 mg
8-Azaadenosine	PRA 10007	≥97%	20 mg;
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)	PRA 10008	≥95%	10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine	PRA 10009	≥95%	100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosine	PRA 10010	≥97%	100 mg; 1 g
Allopurinol riboside	PRA 10011	≥97%	25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine	PRA 10020	≥97%	100 mg; 1 g
3-Deaza-2'-deoxyadenosine	PRA 10025	≥97%	25 mg; 100 mg
7-Deaza-2'-deoxyadenosine	PRA 10030	≥97%	100 mg; 1 g
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
7-Deaza-2'-deoxyguanosine	PRA 10040	≥97%	100 mg; 1 g
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
7-Deaza-2'-deoxyxanthosine	PRA 10050	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine	PRA 10055	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
5-Iodotubercidin	PRA 10095	≥90%	5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10100	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10110	≥97%	100 mg; 1 g
Sangivamycin	PRA 10140	≥97%	10 mg; 25 mg
Toyocamycin	PRA 10150	≥97%	10 mg; 100 mg
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
dNaM	FC 8110	≥97%	25 mg; 100 mg
9-Deaza-2'-deoxyguanosine	PRA 10120	≥97%	10 mg; 100 mg
9-Deazaguanosine	PRA 10130	≥97%	10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine	PYA 11000	≥97%	10 mg; 25 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
2'-Deoxypseudoisocytidine	PYA 11005	≥97%	10 mg; 100 mg
2'-Deoxypseudouridine	PYA 11010	Purity: ≥97%	25 mg;
5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine	PYA 11035	Purity: ≥97%	50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridine	PYA 11040	≥97%	10 mg; 100 mg
1,3-Dimethylpseudouridine	PYA 11050	≥97%	10 mg; 50 mg
N1-Methylpseudouridine	PYA 11052	≥95%	10 mg; 50 mg
N3-Methylpseudouridine	PYA 11054	≥97%	10 mg; 25 mg
Showdomycin	PYA 11056	≥97%	10 mg;
Pseudoisocytidine hydrochloride	PYA 11060	≥97%	10 mg; 100 mg
Pseudothymidine	PYA 11070	≥97%	10 mg; 100 mg
Pseudouridine	PYA 11080	≥97%	10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine	PR 3350	≥97%	10 mg;
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-Deoxy-8,5'-cycloadenosine	PR 3440	≥97%	10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosine	PR 3500	≥97%	10 mg;
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine	PR 3730	≥97%	10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosine	PR 3800	≥97%	10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosine	PR 3810	≥97%	10 mg;
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine	PY 7054	≥97%	25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
5-Bromo-2'-deoxycytidine	PY 7115	≥97%	1 g; 10 g
Cytidine	PY 7215	≥97%	50 g; 500 g
2'-Deoxycytidine	PY 7216	≥97%	10 g; 50 g
2'-Deoxycytidine Hydrochloride	PY 7217	≥97%	5 g; 50 g
5'-Azido-2',5'-dideoxycytidine	PY 7219	≥97%	25 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
N4-Ethyl-2'-deoxycytidine	PY 7245	≥97%	100 mg; 250 mg
5-Methyl-2'-deoxyisocytidine	PY 7255	≥95%	500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7270	≥97%	20 mg; 50 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7380	≥97%	50 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine	PY 7410	≥97%	100 mg;
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one	PY 7540	≥95%	250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydrate	PY 7586	≥95%	50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine	PY 7587	≥97%	10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidine	PY 7588	≥97%	50 mg; 100 mg
5-Formyl-2'-deoxycytidine	PY 7589	≥97%	5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidine	PY 7592	≥95%	25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium salt	PY 7593	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxymethylcytidine	PY 7596	≥97%	50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium salt	PY 7598	≥97%	10 mg; 50 mg
5-Formylcytidine	PY 7599	≥97%	5 mg; 10 mg
5-Iodo-2'-deoxycytidine	PY 7607	≥97%	2 g; 10 g
5-Iodocytidine	PY 7609	≥97%	5 g;
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Methyl-2'-deoxycytidine Hydrochloride	PY 7635	≥97%	0.25 g; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methylcytidine	PY 7637	≥97%	1 g; 5 g
N4-Methylcytidine	PY 7638	≥97%	25 mg; 100 mg
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
2-Thiocytidine	PY 7721	≥97%	10 mg; 100 mg
2-Thio-2'-deoxycytidine	PY 7723	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
8-Hydroxyguanosine	PR 3795	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
5-Aza-2'-deoxycytidine	PY 7105	≥95%	25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidine	PY 7106	≥97%	25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
Nap-dU	PY 7735	≥97%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
8-18O-Hydroxyguanosine	IOPR 3795	≥95%	2 mg; 5 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
N2-Dimethylguanosine	PR 3702	≥97%	10 mg; 100 mg
Guanosine	PR 3703	≥97%	100 g; 500 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
O6-Methylguanosine	PR 3757	≥97%	25 mg; 100 mg
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
8-Bromoguanosine	PR 3796	≥97%	0 g;
8-Benzyloxyguanosine	PR 3797	≥95%	100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
2'-Deoxy-4-desmethylwyosine	PR 3450	≥95%	100 mg; 500 mg
2'-Deoxyinosine	PR 3463	≥97%	10 g; 100 g
5'-Azido-2',5'-dideoxyinosine	PR 3464	≥97%	5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosine	PR 3480	≥97%	1 g;
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine	PR 3490	≥90%	1 g;
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine	PR 3660	≥97%	100 mg; 1 g
Inosine	PR 3725	≥97%	100 g; 500 g
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
O6-Phenyl-2'-deoxyinosine	PR 3840	≥97%	100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3842	≥97%	25 mg;
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3843	≥90%	25 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine	PR 3510	≥90%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3520	≥95%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3530	≥90%	100 mg; 1 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
d5SICS	FC 8120	≥97%	25 mg; 100 mg
AICA Riboside (AICAR)	MN 20001	≥97%	0 g (DISCONTINUED);
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine	PR 3692	≥95%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
tC Nucleoside	PYA 11110	≥97%	50 mg; 100 mg
tCnitro Nucleoside	PYA 11115	≥95%	5 mg; 25 mg
2'-Deoxynebularine	PR 3470	Purity: ≥97%	100 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole	PYA 11020	≥97%	50 mg;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole	PYA 11030	≥95%	100 mg;
Showdomycin	PYA 11056	≥97%	10 mg;
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pseudouridine	PYA 11080	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
Toyocamycin	PRA 10150	≥97%	10 mg;
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg;
Allopurinol riboside	PRA 10011	≥97%	25 mg;
5-Iodotubercidin	PRA 10095	≥90%	5 mg;
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg;
5'-Amino-5'-deoxythymidine	PY 7030	≥97%	25 mg; 50 mg
O2,5'-Anhydrothymidine	PY 7060	≥95%	500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
5'-Azido-5'-deoxythymidine	PY 7070	≥97%	25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7120	≥97%	1 g;
3'-O-(t-Butyldimethylsilyl)thymidine	PY 7130	≥95%	500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidine	PY 7140	≥97%	5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidine	PY 7150	≥97%	1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine	PY 7160	≥95%	100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine	PY 7200	≥95%	10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidine	PY 7210	≥95%	10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7250	≥97%	1 g;
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one	PY 7315	≥90%	1 g; 10 g
2',3'-Didehydro-3'-deoxythymidine	PY 7328	≥95%	10 mg; 100 mg
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine	PY 7510	≥97%	50 mg; 100 mg
2-O-Ethylthymidine	PY 7561	≥97%	500 mg; 1 g
5'-Iodo-5'-deoxythymidine	PY 7610	≥97%	250 mg; 1 g
5'-O-Methylthymidine	PY 7680	≥95%	50 mg; 100 mg
2-Thiothymidine	PY 7725	≥95%	20 mg; 100 mg
Thymidine	PY 7727	≥97%	25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidine	PY 7740	≥97%	5 g;
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidine	PY 7750	≥97%	50 mg;
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
6-Azathymidine	PYA 11058	≥95%	25 mg; 100 mg
NPOM-Caged-dT CEP	BA 0317	≥95%	100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
5-Ethynyl uridine CEP	BA 0353	≥90%	100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridine	PY 7053	≥97%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one	PY 7055	≥97%	20 mg; 100 mg
5-Bromo-2'-deoxyuridine	PY 7117	≥97%	10 g; 25 g
5-Bromouridine	PY 7118	≥95%	5 g;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carbomethoxyvinyl)uridine	PY 7172	≥97%	25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridine	PY 7185	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine	PY 7212	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
2'-Deoxyuridine	PY 7275	≥97%	25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine	PY 7280	≥95%	100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7310	≥97%	20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine	PY 7450	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridine	PY 7465	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-Ethynyl-2'-deoxyuridine	PY 7562	≥97%	25 mg; 100 mg
5-Ethynyl uridine	PY 7563	≥97%	10 mg; 100 mg
5-Fluoro-2'-deoxyuridine	PY 7565	≥97%	100 mg; 1 g
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7580	≥97%	25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7590	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridine	PY 7604	≥97%	25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridine	PY 7612	≥95%	100 mg;
5-Iodo-2'-deoxyuridine	PY 7615	≥97%	10 g; 25 g
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
5-Iodouridine	PY 7632	≥95%	5 g; 25 g
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
3-Methyluridine	PY 7694	≥97%	25 mg; 100 mg
5-Methyluridine	PY 7695	≥97%	200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridine	PY 7712	≥95%	10 mg; 100 mg
Zebularine	PY 7715	≥97%	10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine	PY 7720	≥90%	500 mg; 1 g
2-Thiouridine	PY 7724	≥97%	25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine	PY 7730	≥97%	1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine	PY 7758	≥97%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine	PY 7775	≥97%	100 mg; 1 g
Uridine	PY 7780	≥97%	100 g; 500 g
2'3'-O-Isopropylidene uridine	PY 7781	≥97%	5 g; 25 g
5-Hydroxymethyl uridine	PY 7782	≥97%	50 mg; 100 mg
5-Methoxyuridine	PY 7783	≥97%	10 mg; 50 mg
6-Aza-2'-deoxyuridine	PYA 11057	≥95%	50 mg; 100 mg

" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

...

阅读详情

Welligton实验室始建于1980年，致力于为客户提供高品质的标准物质，并始终站在环境科学的前沿，Wellington以矢志不渝的信念不断地推出新的合成物质，用于检测环境中不断出现的污染物。

Wellington Laboratories has been committed to providing high quality reference standards and exceptional customer service since its inception in 1980. An acute awareness of trends in the environmental community and a dedication to research and development has allowed us to synthesize a variety of emerging contaminants over the years. A few examples of The Science Behind Wellington are provided below for your review.

Wellington Laboratories的主要产品包括：

PCDD/PCDF Analytical Method Solutions

Individual PCDDs & PCDFs: Native and Mass-Labelled

Specialty Solution/Mixtures of PCDDs and PCDFs

PCB Analytical Method Solutions

Individual PCBs: Mass-Labelled

Specialty Solution/Mixtures of PCBs

Halogenated Flame Retardants & Related Compounds

Perfluorinated Compounds (PFCs)

Certified Reference Materials

Additional Products

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Wellington Laboratories"> Wellington Laboratories

...

阅读详情

艾美捷科技代理Ambinter品牌。

Ambinter隶属于Greenpharma品牌，是重要的药物发现专用化合物供应商。Ambinter拥有超过25年的合成经验，其数据库包含超过4600万种用于高通量筛选的化合物、构建模块以及各种片段和天然产物。Ambinter提供具有高度生物活性的复杂和稀有化学品。在Greenpharma的支持下，Ambinter还提供包括定制合成、化学信息学和分子建模、分析化学、研发项目管理在内的服务项目。

< " data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Ambinter品牌"> 艾美捷科技代理Ambinter品牌

...

阅读详情

Mirus Bio公司是世界上最早开发高效、低细胞毒性转染试剂的公司之一，同时也是目前该类试剂最主要的供应商之一。Mirus Bio的大部分转染试剂可以在含有血清的培养基中进行转染，省去了更换培养基的麻烦。TransIT-L1是Mirus产品的王牌，自1995年开发出来就申请了美国专利(US 5,744,335)。该项专利技术后来License给了Roche公司，以Fugene 6的品牌对外销售。TransIT-TKO & siQUEST转染试剂是常规siRNA转染试剂的王牌，与脂质体介导的转染试剂相比，该转染试剂可以高效转染siRNA，并且极大地降低了细胞的损伤程度。该试剂与siRNA混合转染细胞时，可以特异性剔除某些基因的表达，用于siRNA介导的基因沉默现象的研究。TransIT-Oligo转染试剂是即用型试剂，可以高效地将各种类型的寡聚核苷酸和寡聚脱氧核苷酸转染至受体细胞中。

此外，Mirus Bio还开发了专门针对特殊细胞的体外转染试剂，例如分别针对Jurkat，COS，3T3等细胞的转染试剂。Mirus Bio的科学家们新近开发了一种新的DNA转染试剂：TransITTM-2020 Transfection Reagent。TransITTM的性能优于FuGENETM、LipofectamineTM 2000和 LipofectamineTM 2000 CD；可在多种类型的细胞（包括难转染细胞）中实现高表达。

Mirus was founded on the principle that non-viral (i.e. plasmid DNA based) methods offer distinct advantages over viral methods of gene transfer. Our initial breakthrough in 1996 came with the development of a new type of transfection reagent that combined high efficiency delivery with low cellular toxicity: TransIT®-LT1 (Low Toxicity) Reagent remains the “gold standard” for broad-based gene delivery applications.

Mirus Bio公司主要产品：

Transfection with TransIT

Ingenio® Electroporation

Virus Production

Labeling with Label IT®

In Vivo Delivery

Accessory Products

品名	货号
Human IgG1 Expression Control – 100 ug	MIR 6250
Ingenio EZporator Electroporation System	MIR 51000
Label IT Nucleic Acid Labeling Kit, Amine – sufficient for modifying 25 µg of nucleic acid	MIR 3925
Label IT Nucleic Acid Labeling Kit, Amine – sufficient for modifying 100 µg of nucleic acid	MIR 3900
TransIT-2020 Transfection Reagent – 0.4 mL	MIR 5404
TransIT-2020 Transfection Reagent – 1.0 mL	MIR 5400
TransIT-2020 Transfection Reagent – 10 X 1.0 mL	MIR 5406
TransIT-2020 Transfection Reagent – 5 X 1.0 mL	MIR 5405
TransIT-293 Transfection Reagent – 0.4 mL	MIR 2704
TransIT-293 Transfection Reagent – 1.0 mL	MIR 2700
TransIT-293 Transfection Reagent – 10 X 1.0 mL	MIR 2706
TransIT-293 Transfection Reagent – 5 X 1.0 mL	MIR 2705
TransIT-CHO Transfection Kit – 10 X 1.0 mL	MIR 2176
TransIT-CHO Transfection Kit – 5 X 1.0 mL	MIR 2175
TransIT-CHO Transfection Kit – 1.0 mL	MIR 2170
TransIT-HeLaMONSTER Transfection Kit – 0.4 mL	MIR 2904
TransIT-HeLaMONSTER Transfection Kit – 1.0 mL	MIR 2900
TransIT-HeLaMONSTER Transfection Kit – 10 X 1.0 mL	MIR 2906
TransIT-HeLaMONSTER Transfection Kit – 5 X 1.0 mL	MIR 2905
TransIT-Insect Transfection Reagent – 0.4 mL	MIR 6104
TransIT-Insect Transfection Reagent – 1.0 mL	MIR 6100
TransIT-Insect Transfection Reagent – 10 X 1.0 mL	MIR 6106
TransIT-Insect Transfection Reagent – 5 X 1.0 mL	MIR 6105
TransIT-Jurkat Transfection Reagent – 0.4 mL	MIR 2124
TransIT-Jurkat Transfection Reagent – 1.0 mL	MIR 2120
TransIT-Jurkat Transfection Reagent – 10 X 1.0 mL	MIR 2126
TransIT-Jurkat Transfection Reagent – 5 X 1.0 mL	MIR 2125
TransIT-Keratinocyte Transfection Reagent – 0.4 mL	MIR 2804
TransIT-Keratinocyte Transfection Reagent – 1.0 mL	MIR 2800
TransIT-Keratinocyte Transfection Reagent – 10 X 1.0 mL	MIR 2806
TransIT-Keratinocyte Transfection Reagent – 5 X 1.0 mL	MIR 2805
TransIT-LT1 Transfection Reagent – 0.4 mL	MIR 2304
TransIT-LT1 Transfection Reagent – 5 X 1.0 mL	MIR 2305
TransIT-mRNA Transfection Kit – 0.4 mL	MIR 2225
TransIT-mRNA Transfection Kit – 1.0 mL	MIR 2250
TransIT-mRNA Transfection Kit – 10 X 1.0 mL	MIR 2256
TransIT-mRNA Transfection Kit – 5 X 1.0 mL	MIR 2255
TransIT-Oligo Transfection Reagent – 0.4 mL	MIR 2164
TransIT-Oligo Transfection Reagent – 1.0 mL	MIR 2160
TransIT-Oligo Transfection Reagent – 10 X 1.0 mL	MIR 2166
TransIT-Oligo Transfection Reagent – 5 X 1.0 mL	MIR 2165
TransIT-PRO Transfection Kit – 1.0 mL (with boost)	MIR 5700
TransIT-PRO Transfection Kit – 10 mL (with boost)	MIR 5760
TransIT-PRO Transfection Reagent – 1 mL (without boost)	MIR 5740
TransIT-PRO Transfection Reagent – 10 mL (without boost)	MIR 5750
TransIT-siQUEST Transfection Reagent – 0.4 mL	MIR 2114
TransIT-siQUEST Transfection Reagent – 1.5 mL	MIR 2110
TransIT-siQUEST Transfection Reagent – 10 X 1.5 mL	MIR 2116
TransIT-siQUEST Transfection Reagent – 5 X 1.5 mL	MIR 2115
TransIT-TKO Transfection Reagent – 0.4 mL	MIR 2154
TransIT-TKO Transfection Reagent – 1.5 mL	MIR 2150
TransIT-TKO Transfection Reagent – 10 X 1.5 mL	MIR 2156
TransIT-TKO Transfection Reagent – 5 X 1.5 mL	MIR 2155
TransIT-X2 Dynamic Delivery System – 0.3 mL	MIR 6003
TransIT-X2 Dynamic Delivery System – 0.75 mL	MIR 6004
TransIT-X2 Dynamic Delivery System – 1.5mL	MIR 6000
TransIT-X2 Dynamic Delivery System – 10 X 1.5 mL	MIR 6006
TransIT-X2 Dynamic Delivery System – 5 X 1.5 mL	MIR 6005
Ingenio Electroporation Accessory – Cell Droppers (50 pk)	MIR 50125
Ingenio Electroporation Solution Only – 25 rxns (6.25 mL)	MIR 50111
Label IT Nucleic Acid Labeling Kit, Biotin – labels 100 µg nucleic acid	MIR 3400
Label IT Plasmid Delivery Control, Cy3 – 10 µg	MIR 7904
Label IT RNAi Delivery Control, Cy3 – 10 µg (0.75 nmol)	MIR 7900
TransduceIT Transduction Reagent – 1 mL	MIR 6620
TransIT-BrCa Reagent Transfection Reagent – 0.4 mL	MIR 5504
Ingenio Electroporation Accessory – 0.4 cm Cuvettes (50 pk)	MIR 50123
Ingenio Electroporation Solution Only – 50 rxns (12.5 mL)	MIR 50114
Label IT Nucleic Acid Labeling Kit, Biotin – labels 25 µg nucleic acid	MIR 3425
Label IT Plasmid Delivery Control, Cy3 – 100 µg	MIR 7905
Label IT RNAi Delivery Control, Cy3 – 100 µg (7.5 nmol)	MIR 7901
Label IT siRNA Tracker Intracellular Localization Kit, CX-Rhodamine – labels 50 µg siRNA	MIR 7214
Label IT Tracker Intracellular Nucleic Acid Localization Kit, CX-Rhodamine – labels 50-200 µg plasmid DNA	MIR 7022
Lentivirus Packaging Mix – 34 rxn	MIR 6640
TransIT-BrCa Reagent Transfection Reagent – 1.0 mL	MIR 5500
TransIT-LT1 Transfection Reagent – 1.0 mL	MIR 2300
Ingenio Electroporation Accessory – 0.2 cm Cuvettes (50 pk)	MIR 50121
Ingenio Electroporation Solution Only – 100 rxns (25 mL)	MIR 50117
Label IT Nucleic Acid Labeling Kit, CX-Rhodamine – labels 100 µg nucleic acid	MIR 3100
Label IT Plasmid Delivery Control, Fluorescein – 10 µg	MIR 7906
Label IT RNAi Delivery Control, Fluorescein – 10 µg (0.75 nmol)	MIR 7902
Label IT siRNA Tracker Intracellular Localization Kit, Cy3 – labels 50 µg siRNA	MIR 7212
Label IT Tracker Intracellular Nucleic Acid Localization Kit, Cy3 – labels 50-200 µg plasmid DNA	MIR 7020
Lentivirus Packaging Mix – 5 rxn	MIR 6630
TransIT-BrCa Transfection Reagent – 5 x 1.0 mL	MIR 5505
Ingenio Electroporation Kit, for Amaxa – 25 rxns (0.2 cm Cuvettes/Droppers)	MIR 50112
Label IT Nucleic Acid Labeling Kit, CX-Rhodamine – labels 25 µg nucleic acid	MIR 3125
Label IT Plasmid Delivery Control, Fluorescein – 100 µg	MIR 7907
Label IT RNAi Delivery Control, Fluorescein – 100 µg (7.5 nmol)	MIR 7903
Label IT siRNA Tracker Intracellular Localization Kit, Cy5 – labels 50 µg siRNA	MIR 7213
Label IT Tracker Intracellular Nucleic Acid Localization Kit, Cy5 – labels 50-200 µg plasmid DNA	MIR 7021
TransIT Lentivirus System – 34 rxn	MIR 6655
TransIT-BrCa Transfection Reagent – 10 x 1.0 mL	MIR 5506
TransIT-LT1 Transfection Reagent – 10 X 1.0 mL	MIR 2306
Ingenio Electroporation Kit, for Amaxa – 50 rxns (0.2 cm Cuvettes/Droppers)	MIR 50115
Label IT Nucleic Acid Labeling Kit, Cy3 – labels 100 µg nucleic acid	MIR 3600
Label IT siRNA Tracker Intracellular Localization Kit, Fluorescein – labels 50 µg siRNA	MIR 7216
Label IT Tracker Intracellular Nucleic Acid Localization Kit, Fluorescein – labels 50-200 µg plasmid DNA	MIR 7025
TransIT Lentivirus System – 5 rxn	MIR 6650
Ingenio Electroporation Kit, for Amaxa – 100 rxns (0.2 cm Cuvette/Droppers)	MIR 50118
Label IT Nucleic Acid Labeling Kit, Cy3 – labels 25 µg nucleic acid	MIR 3625
TransIT-Lenti Transfection Reagent – 10 x 1.5 mL	MIR 6606
Ingenio Electroporation Kit, for other Electroporators – 25 rxns, (0.4 cm Cuvettes/Droppers)	MIR 50113
Label IT Nucleic Acid Labeling Kit, Cy5 – labels 100 µg nucleic acid	MIR 3700
TransIT-Lenti Transfection Reagent – 1.5 mL	MIR 6600
Ingenio Electroporation Kit, for other Electroporators – 50 rxns (0.4 cm Cuvettes/Droppers)	MIR 50116
Label IT Nucleic Acid Labeling Kit, Cy5 – labels 25 µg nucleic acid	MIR 3725
TransIT-Lenti Transfection Reagent – 0.75 mL	MIR 6604
Ingenio Electroporation Kit, for other Electroporators – 100 rxns (0.4 cm Cuvette/Droppers)	MIR 50119
TransIT-Lenti Transfection Reagent – 5 x 1.5 mL	MIR 6605
TransIT-Lenti Transfection Reagent – 0.3 mL	MIR 6603
Label IT Nucleic Acid Labeling Kit, DNP – labels 100 µg nucleic acid	MIR 3800
Label IT Nucleic Acid Labeling Kit, DNP – labels 25 µg nucleic acid	MIR 3825
Label IT Nucleic Acid Labeling Kit, Fluorescein – labels 100 µg nucleic acid	MIR 3200
Label IT Nucleic Acid Labeling Kit, Fluorescein – labels 25 µg nucleic acid	MIR 3225
Label IT Nucleic Acid Labeling Kit, MFP488 – labels 100 µg nucleic acid	MIR 7100
Label IT Nucleic Acid Labeling Kit, MFP488 – labels 25 µg nucleic acid	MIR 7125
TransIT-EE Delivery Solution – 40 Injections	MIR 5340
TransIT-QR Delivery Solution – 40 Injections	MIR 5240
pLIVE Vector – 20 ug	MIR 5420
pLIVE Vector/LacZ – 20 ug of each vector	MIR 5520
pLIVE Vector/SEAP Control Vector Kit – 20 ug of each vector	MIR 5620
pLIVE Vector Complete System – 20 ug of each vector	MIR 5320
RevIT AAV Enhancer – 1.5 mL (for 1 L of cell culture)	MIR 8000
TransIT-VirusGEN GMP Transfection Reagent – 150 mL	MIR 6845-GMP
VirusGEN AAV Transfection Kit – 150mL	MIR 6755
VirusGEN AAV Transfection Kit, 1 Kit – for 10 L of cell culture	MIR 6745
RevIT AAV Enhancer – 10 x 1.5 mL (for 10 L of cell culture)	MIR 8006
RevIT AAV Enhancer – 75 mL (for 50 L of cell culture)	MIR 8080
VirusGEN GMP LV Transfection Kit	MIR 6825-GMP
VirusGEN LV Transfection Kit	MIR 6760
VirusGEN AAV Kit + RevIT for 10L Culture	MIR 8008
VirusGEN GMP AAV Transfection Kit	MIR 6815-GMP
VirusGEN AAV Transfection Kit – 1 Kit for 1 L of cell culture	MIR 6750
VirusGEN AAV Kit + RevIT for 1L Culture	MIR 8007
TransIT-VirusGEN Transfection Reagent – 150 mL	MIR 6740
TransIT-VirusGEN Transfection Reagent – 30 mL	MIR 6720
TransIT-VirusGEN Transfection Reagent – 10 x 1.5 mL	MIR 6706
TransIT-VirusGEN Transfection Reagent – 5 x 1.5 mL	MIR 6705

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Mirus Bio"> Mirus Bio

...

阅读详情

168 169 170 171 172 173 174 175 176 177

城市分站

友情链接 invivoCrown IV0103替换BioXCell BE0075-1 invivoCrown IV0120替换BioXCell BE0015-1 invivoCrown IV0112替换BioXCell BE0131 invivoCrown IV0115替换BioXCell BE0060 invivoCrown IV0114替换BioXCell BE0213 Buhlmann 艾美捷科技特约代理Biosettia公司产品 AllerMAbs ProSci Boston Biochem

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：18327026838

传真：18372041646

邮箱：sales@amyjet.com

0.284